A Phase 2 Study of LY2495655 in Participants With Pancreatic Cancer

Mise à jour : Il y a 4 ans
Référence : NCT01505530

Femme et Homme

Extrait

This phase 2 study is a multicenter, randomized, double-blind, placebo-controlled trial in participants with locally advanced/inoperable or metastatic pancreatic cancer, and will investigate 2 different doses of LY2495655 in combination with standard of care chemotherapy.


Critère d'inclusion

  • Pancreatic cancer


Liens